Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Mirum Pharmaceuticals Inc
MIRM | US
88.78
USD2.48
2.87%
MIRM | US
About Mirum Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
88.78
Open
86.15
High
89.17
Low
84.33
Mirum Pharmaceuticals Inc. a biopharmaceutical company focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of primary sclerosing cholangitis and primary biliary cholangitis in adults. Mirum Pharmaceuticals Inc. was incorporated in 2018 and is headquartered in Foster City California.
View LessMIRM | US
Risk
66.1
Sharpe
2.31
Luna's Score
48/100
Recommendation
Hold
Luna says (MIRM | US)
What's Working
Strength based on increasing price with high volume
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
High Short-term Volatility
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
87.2%1 month
66.1%3 months
54.3%6 months
43.9%Returns
Fundamental Ratios
PE
-
Fwd. PE
39.68
Price to book
8.19
Debt to equity
1.38
Debt to assets
0.48
Ent. to EBITDA
-8.85
Ent. to rev.
7.24
PEG
-
Other Fundamentals
EBITDA
-88.76M
MarketCap
4.24B
MarketCap(USD)
4.24B
Div. yield
-
Op. margin
-31.12
Erngs. growth
-
Rev. growth
107.70
Ret. on equity
-70.98
Short ratio
17.96
Short perc.
17.44
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
24.95
Range1M
24.95
Range3M
46.05
Volumes: Market Activity
Rel. volume
1.42
Price X volume
97.60M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -8.85 | 0.53 | Cheaper |
| Ent. to Revenue | 7.24 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 8.19 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 54.27 | 72.80 | Lower Risk |
| Debt to Equity | 1.38 | -1.23 | Expensive |
| Debt to Assets | 0.48 | 0.25 | Expensive |
| Market Cap | 4.24B | 3.66B | Par |
